XML 31 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Incentive Plans
12 Months Ended
Dec. 31, 2011
Stock Incentive Plans [Abstract]  
Stock Incentive Plans

7. STOCK INCENTIVE PLANS

The Company sponsored a stock option plan, the 2001 Equity Plan (the "2001 Plan"), which allowed for the granting of incentive and nonqualified stock options for the purchase of common stock. The maximum number of shares which could be awarded or sold under the 2001 Plan was 1,449,667 shares. Each option entitles the holder to purchase one share of common stock at the specified option exercise price. The exercise price of each incentive stock option granted must not be less than the fair market value on the grant date. At the discretion of management and with the approval of the Board of Directors, the Company granted options under the 2001 Plan. Management and the Board of Directors determined vesting periods and expiration dates at the time of the grant. On August 2, 2011, the plan expired.

In August 2007, the Company adopted the 2007 Plan, which allows for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and bonus shares. On June 22, 2011, the stockholders of the Company approved an amendment to the 2007 Plan to increase the maximum number of shares that may be awarded or sold under the 2007 Plan by 2,100,000 from 2,307,692 to 4,407,692 shares. The Board of Directors has appointed a committee to administer the plan. The plan committee determines the type of award to be granted, the fair market value, the number of shares covered by the award, and the time when the award vests and may be exercised.

The following table summarizes the activity of the stock incentive and equity plans:

 

     Shares
available
for grant
    Number of
options
outstanding
    Weighted-
average
option
exercise price
     Number of
restricted
stock and
board shares
issued
 

Outstanding at December 31, 2008

     2,072,170        1,160,847      $ 8.00         26,503   

Granted

     (1,274,827     1,266,467        9.71         8,360   

Exercised

     —          (150,621     2.79         —     

Canceled/forfeited

     76,926        (82,407     4.34         —     
  

 

 

   

 

 

   

 

 

    

 

 

 

Outstanding at December 31, 2009

     874,269        2,194,286        9.48         34,863   

Granted

     (238,826     238,826        27.54         —     

Exercised

     —          (594,308     5.86         —     

Canceled/forfeited

     8,407        (8,407     16.63         —     
  

 

 

   

 

 

   

 

 

    

 

 

 

Outstanding at December 31, 2010

     643,850        1,830,397        12.98         34,863   

Authorized

     2,100,000        —          —           —     

Granted

     (389,774     382,050        16.02         7,724  

Exercised

     —          (73,428     10.78         —     

Expired

     (139,988     —          —           —     

Canceled/forfeited

     45,911        (45,911     20.15         —     
  

 

 

   

 

 

   

 

 

    

 

 

 

Outstanding at December 31, 2011

     2,259,999        2,093,108      $ 13.45         42,587   
  

 

 

   

 

 

   

 

 

    

 

 

 

 

The following table sets forth option grants made during 2011, 2010 and 2009 with intrinsic value calculated based on grant date fair value.

 

Date of Grant

   Number of
options
granted
     Exercise
price
     Intrinsic
value
per share
 

February 2009

     759,967       $ 4.01        —     

April - May 2009

     18,500         7.75 - 8.06         —     

July - September 2009

     27,000         10.02 - 12.16         —     

October 2009

     11,000         14.57 - 16.93         —     

December 2009

     450,000         19.21         —     

February 2010

     7,500         15.00         —     

March - April 2010

     50,671         19.49 - 20.20         —     

June - August 2010

     145,655         24.95 - 32.67         —     

October 2010

     35,000         22.69         —     

January 2011

     26,000         18.80 - 21.64         —     

March - April 2011

     73,500         25.61 - 27.63         —     

May 2011

     51,650         22.92         —     

July 2011

     12,500         16,86         —     

October 2011

     75,400         10.81 - 10.93         —     

December 2011

     143,000         10.19         —     

At December 31, 2011, the exercise prices of outstanding options were as follows:

 

Exercise Price

   Number of
options
outstanding
     Average
remaining
contractual life
(years)
     Number of
options
exercisable
 

$ 0.78 - $4.94

     581,343         5.95         257,541   

7.75 - 8.45

     270,739         5.68         261,489   

10.02 - 14.00

     370,692         9.57         139,442   

14.57 - 18.80

     78,104         8.31         54,729   

19.21 - 22.92

     575,250         8.74         29,175   

24.95 - 32.67

     216,980         8.61         37,555   
  

 

 

       

 

 

 
     2,093,108         7.93         779,931   
  

 

 

       

 

 

 

The weighted average fair value of the options vested in the years ended 2011, 2010 and 2009 was $3.9 million, $2.9 million and $2.0 million, respectively.

 

The following table summarizes the activity of non-vested options as follows:

 

     Non-vested
options
    Weighted-
Average Option
Exercise
price
 

Non-vested at December 31, 2008

     581,131      $ 9.18   

Granted

     1,266,467        9.71   

Vested

     (269,753     7.25   

Cancelled

     (77,205     4.32   
  

 

 

   

 

 

 

Non-vested at December 31, 2009

     1,500,640        10.22   

Granted

     238,826        27.54   

Vested

     (391,788     7.29   

Cancelled

     (8,292     16.70   
  

 

 

   

 

 

 

Non-vested at December 31, 2010

     1,339,386        14.12   

Granted

     382,050        16.02   

Vested

     (366,484     10.72   

Cancelled

     (41,775     20.39   
  

 

 

   

 

 

 

Non-vested at December 31, 2011

     1,313,177      $ 13.58   
  

 

 

   

 

 

 

The Company's aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock options and the fair value of the Company's common stock. Based on the fair market value of the common stock at December 31, 2011, there was no aggregate intrinsic value for options outstanding and exercisable. At December 31, 2010, the intrinsic value for the options outstanding was $14.8 million and the intrinsic value for the options exercisable was $5.5 million. The Company uses the Black-Scholes option pricing model to value stock options. The Company uses historical stock prices of companies which it considers as a peer group as the basis for its volatility assumptions. The assumed risk-free rates were based on U.S. Treasury rates in effect at the time of grant with a term consistent with the expected option lives. The expected term is based upon the vesting term of the Company's options, a review of a peer group of companies, and expected exercise behavior. The forfeiture rate is based on past history of forfeited options. The expense is being allocated using the straight-line method. For the years ended December 31, 2011, 2010 and 2009, the Company recorded $2.3 million, $2.1 million and $823,000, respectively of stock option compensation expense. As of December 31, 2011, the Company has $5.1 million of total unrecognized compensation cost related to nonvested awards granted under the Company's stock-based plans that it expects to recognize over a weighted-average period of 2.72 years.

The Company continues to account for options issued prior to January 1, 2006 under the intrinsic value method.

The weighted average fair value per share of options granted for the fiscal year ended December 31, 2011 was $16.02 and the fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model using an expected term of 5.0 years, risk-free interest rate of .85%—2.24%, expected volatility of 51% and no dividend yield. The Company used an expected forfeiture rate of 24.53% in 2011.

The weighted average fair value per share of options granted for the fiscal year ended December 31, 2010 was $27.54 and the fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model using an expected term of 5.4 years, risk-free interest rate of 1.26%—2.60%, expected volatility of 60% and no dividend yield. The Company used an expected forfeiture rate of 27.54% in 2010.

 

The weighted average fair value per share of options granted for the fiscal year ended December 31, 2009 was $9.71 and the fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model using an expected term of 5.2 years, risk-free interest rate of 0.37%—1.41%, expected volatility of 50% and no dividend yield. The Company used an expected forfeiture rate of 30% in 2009.

An analysis of restricted stock issued is as follows:

 

Non-vested restricted stock as of December 31, 2009

     8,453   

Vested

     (6,691
  

 

 

 

Non-vested restricted stock as of December 31, 2010

     1,762   

Granted

     7,724  

Vested

     (7,555
  

 

 

 

Non-vested restricted stock as of December 31, 2011

     1,931   
  

 

 

 

For the years ended December 31, 2011, 2010 and 2009, the Company recorded $165,000, $153,000 and $114,000, respectively, of stock compensation expense related to restricted stock.

In 2009, the Board of Directors awarded stock options to purchase 300,000 shares of common stock to key executives at an exercise price of $19.21, the closing price of the shares on the date of the grant. Vesting of the options is subject to achievement of specified annual revenue and net earnings targets by December 31, 2012. The Company is recording stock compensation expense related to these options based on the probability of achieving the targets. At December 31, 2011, the Company considered one of the milestones of these targets to be improbable, and therefore did not record any expense.